ArticleScientific reports2025

Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathway.

Khanh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.